✦ LIBER ✦

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

✍ Scribed by Pfeifer, H; Wassmann, B; Bethge, W; Dengler, J; Bornhäuser, M; Stadler, M; Beelen, D; Vucinic, V; Burmeister, T; Stelljes, M; Faul, C; Dreger, P; Kiani, A; Schäfer-Eckart, K; Schwerdtfeger, R; Lange, E; Kubuschok, B; Horst, H A; Gramatzki, M; Brück, P; Serve, H; Hoelzer, D; Gökbuget, N; Ottmann, O G

Book ID: 120330293
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 729 KB
Volume: 27
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2012.352

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pre-transplant imatinib-based therapy im

Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia

✍ Mizuta, S; Matsuo, K; Yagasaki, F; Yujiri, T; Hatta, Y; Kimura, Y; Ueda, Y; Kana 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 358 KB

Comparison of Chimerism and Minimal Resi

Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction after Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia

✍ Terwey, Theis Helge; Hemmati, Philipp Georg; Nagy, Marion; Pfeifer, Heike; Gökbu 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Successful Treatment of Minimal Residual

Successful Treatment of Minimal Residual Disease—Positive Philadelphia Chromosome—Positive Acute Lymphoblastic Leukemia with Imatinib Followed by Reduced-Intensity Unrelated Cord Blood Transplantation after Allogeneic Peripheral Blood Stem Cell Transplantation

✍ Akiyoshi Takami; Shigeru Shimadoi; Chiharu Sugimori; Kenichi Takemoto; Masami Sh 📂 Article 📅 2006 🏛 Carden Jennings Publishing 🌐 English ⚖ 92 KB

The extent of minimal residual disease r

The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

✍ Seok Lee; Yoo-Jin Kim; Nak-Gyun Chung; Jihyang Lim; Dong-Gun Lee; Hee-Je Kim; Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

## Abstract ## BACKGROUND: Previously, the authors demonstrated the positive impact of imatinib on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph‐positive ALL). Here, the authors analyzed for risk factors that af

Quantitative assessment of WT1 gene expr

Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia

✍ Anna Candoni; Mario Tiribelli; Eleonora Toffoletti; Daniela Cilloni; Alexia Chia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

The value of monitoring minimal residual

The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

✍ Xiao Ma; Depei Wu; Aining Sun; Huiying Qiu; Zhenzhen Fu; Xiaojin Wu; Suning Chen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views